Navigation Links
LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
Date:9/5/2007

5. Get Involved in Your Health: Knowing about your risks is the first step

in getting healthier. Once you are aware, take action to work toward a

healthier you. Find out about your family medical history and know what

genetic history you have related to high cholesterol and heart disease.

Bring this information to your doctor's attention so that you can work

together to form a program that works best for you.

About LifeMasters Supported SelfCare, Inc.

LifeMasters Supported SelfCare, Inc. is a leading provider of disease management programs and services that create health partnerships among individuals, their physicians and payors. Its mission is to empower individuals to achieve and maintain optimal health. The programs improve quality of care for people with chronic illnesses, reduce chronic-disease costs for payors and provide decision-support tools for physicians. LifeMasters offers programs for individuals with diabetes, congestive heart failure (CHF), coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), hypertension and asthma (all of which are fully accredited by the National Committee for Quality Assurance (NCQA) and URAC), cancer, metabolic syndrome and musculo-skeletal pain. LifeMasters' programs are holistically focused, support co-morbidities such as depression and facilitate lifestyle changes such as smoking cessation and weight loss. LifeMasters provides services to over 650,000 people throughout the nation.

Founded in 1994 by a physician, LifeMasters works with some of the nation's leading health plans, employers, retirement systems and governmental organizations, including Aetna, BlueCross BlueShield of Tennessee, State Teachers Retirement System of Ohio, and Presbyterian Health Services in New Mexico. More information about LifeMasters can be found at http://www.lifemasters.com or by calling 1-800-777-1307.<
'/>"/>

SOURCE LifeMasters Supported SelfCare, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Acupuncture provides relief
2. Micro-camera provides new breast imaging technique
3. MicroRNA provides new insight into birth defects
4. Hormone therapy provides no heart benefit
5. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
6. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
7. Cholesterol provides immunity against infection by certain parasites
8. John Hopkins CGHH program provides Global Health education
9. Protein provides antioxidant protection to Neurons
10. London Hospital Provides Specialized Care For Pregnant Women
11. Study Provides Evidence That Obesity Leads To A More Aggressive Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 1U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 2U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 3U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 4U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 5West to Present at Two Upcoming Investor Conferences 56960 1West to Present at Two Upcoming Investor Conferences 56960 2Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults 56959 1Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults 56959 2